Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H14O5 |
Molecular Weight | 286.2794 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(OC(=O)C2=C(OC(C)=O)C=CC=C2)C=CC=C1
InChI
InChIKey=HSJFYRYGGKLQBT-UHFFFAOYSA-N
InChI=1S/C16H14O5/c1-11(17)20-13-8-4-3-7-12(13)16(18)21-15-10-6-5-9-14(15)19-2/h3-10H,1-2H3
Molecular Formula | C16H14O5 |
Molecular Weight | 286.2794 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Guacetisal (Broncaspin) is a bronchomucotropic synthesized by the Bayer Italia S.p.A. Research Laboratories. It is obtained from the esterification of acetylsalicylic acid with guaiacol. Guacetisal was used for the treatment of chronic bronchitis and other inflammatory diseases of the respiratory tract. Guacetisal, used rectally, proved to be a valuable instrument for anti-inflammatory and anti-cough treatment in acute diseases of the airways in infancy.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7017493
Curator's Comment: Also used orally: a Broncaspin suspension was administered for an average of 6-7 days (1/2 teaspoonful twice a day to patients up to 3 yr old; 1 teaspoonful twice a day to those over 3) in the treatment of acute febrile diseases of the upper airways in 16 male and 14 female children aged 5 months to 5 and 3/12 yr. https://www.ncbi.nlm.nih.gov/pubmed/7243038
Broncaspin (guacetisal) has been administered rectally to 42 children suffering from inflammatory diseases of the upper and lower airways, most cases being complicated by bronchospasm. Treatment involving a dose of 1-2 suppositories of 0.5 g/die up to six years of age, and 2 suppositories/die after the sixth year always produced a good antipyretic and anti-cough effect.
Route of Administration:
Rectal
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:29:12 GMT 2023
by
admin
on
Fri Dec 15 15:29:12 GMT 2023
|
Record UNII |
T6EKB9V2O2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N02BA14
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
||
|
WHO-VATC |
QN02BA14
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2105097
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY | |||
|
1333
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY | |||
|
T6EKB9V2O2
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY | |||
|
C023557
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY | |||
|
m2111
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000084240
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY | |||
|
4512
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY | |||
|
SUB07968MIG
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY | |||
|
259-663-1
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY | |||
|
DTXSID40204060
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY | |||
|
68749
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY | |||
|
Guacetisal
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY | |||
|
C65821
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY | |||
|
55482-89-8
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY | |||
|
DB13538
Created by
admin on Fri Dec 15 15:29:12 GMT 2023 , Edited by admin on Fri Dec 15 15:29:12 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |